NBC San Diego
Jim Cramer says Eli Lilly isn't a ‘one trick pony' after FDA advisers endorse its Alzheimer's drug
Continually confident about Eli Lilly because of the enormous success of its weight loss and diabetes drugs, CNBC's Jim Cramer said the company's new Alzheimer's treatment has the potential ...
3 days ago